沙美特罗替卡松粉吸入剂联合茶碱缓释片治疗慢性阻塞性
肺疾病患者的生活质量评价
黄少丹;黎丽旋;叶丽珍;阮淑贞
【期刊名称】《广州医学院学报》 【年(卷),期】2011(039)005
【摘要】目的:探讨沙美特罗替卡松粉吸入剂(舒利迭)联合茶碱缓释片(舒弗美)治疗前后,慢性阻塞性肺疾病(COPD)患者生活质量的变化.方法:收集2008年6月至12月本院呼吸内科80例COPD患者,使用舒利迭联合舒弗美治疗,应用圣乔治呼吸问卷(SGRQ)记录治疗前、治疗1个月、治疗3个月后COPD患者的SGRQ评分,比较治疗过程中患者生活质量的改变.结果:治疗3个月,死亡或失去联系的患者共19人.治疗前、治疗1个月、3个月COPD患者SGRQ呼吸症状评分分别为59±17、52±20、46±16,SGRQ活动能力评分分别为71±24、61±30、59±29,SGRQ疾病影响评分分别为45±21、33±24、27±21,SGRQ总分分别为55±18、45±23、40±20.与治疗前比较,治疗1个月、3个月后COPD患者SGRQ的3部分评分及总分均显著降低(均P＜0.05),而治疗1个月与治疗3个月后的3部分评分及总分比较差异无统计学意义(均P＞0.05).结论:应用舒利迭和舒弗美联合用药治疗1个月可明显改善COPD患者的生活质量,且疗效稳定.%Objective: To evaluate life quality of patients with chronic obstructive pulmonary disease (COPD) treated with Seretide and Theo-Dur. Method:Data of 80 COPD patients treated with Seretide combined with Theo-Dur in the respiratory department of our hospital from June to December of 2008 were collected. St George's Respiratory
Questionnaire (SGRQ) was employed to record the SCRQ score before treatment, 1 month and 3 months after treatment to compare the changes in life quality. Result; 19 patients dead or lost contact 3 months after treatment. SGRQ symptoms scores before treatment, 1 month and 3 months after treatment were respectively (59 ± 17) ,(52 ±20) ,(46 ± 16); SGRQ activity scores were (71 ±24),(61 ±30) , (59 ±29); SGRQ impacts scores were (45 ±21) ,(33 ±24) ,(27 ±21); the total SGRQ score were (55 ± 18) ,(45 ±23) , (40 ±20) ,respectively. Compared with those before treatment,the symptoms,activity and impact sores and the total scores significantly decreased 1 month and 3 months later after treatment (P < 0. 05). However, no significant difference was found between scores 1 month later and scores 3 months later after treatment ( P > 0. 05). Conclusion: Seretide combined with Theo-Dur for one month can significantly improve the life quality of COPD patients,the effect of which is stable. 【总页数】3页(33-35)
【关键词】肺疾病;慢性阻塞性;圣乔治呼吸问卷;生活质量 【作者】黄少丹;黎丽旋;叶丽珍;阮淑贞
【作者单位】广州医学院第二附属医院呼吸内科,广东广州510260;广州医学院2005级临床医疗系,广东广州510182;广州医学院2005级临床医疗系,广东广州510182;广州医学院2005级临床医疗系,广东广州510182 【正文语种】中文
【中图分类】R563 【文献来源】
https://www.zhangqiaokeyan.com/academic-journal-cn_journal-guangzhou-medical-college_thesis/0201244259967.html 【相关文献】
1.茶碱缓释片联合沙美特罗替卡松粉吸入剂对慢性阻塞性肺疾病患者的疗效及对其生活质量的影响 [J], 赵波; 刘峰; 邹小广
2.噻托溴铵吸入剂与沙美特罗替卡松粉吸入剂联合治疗对中重度慢性阻塞性肺疾病稳定期患者肺功能和生活质量的影响 [J], 韦永刚; 付德安
3.小剂量茶碱缓释片和沙美特罗替卡松粉吸入剂联合治疗慢性阻塞性肺疾病的可行性研究 [J], 李德华; 李敏
4.小剂量茶碱缓释片联合沙美特罗替卡松粉吸入剂治疗慢性阻塞性肺疾病50例临床观察 [J], 王晓晟; 吕静; 宋展; 周丽荣
5.噻托溴铵吸入剂联合沙美特罗替卡松粉吸入剂对中重度慢性阻塞性肺疾病患者稳定期的肺功能及预后的影响 [J], 金忠富; 何小花; 王玲霞
以上内容为文献基本信息，获取文献全文请下载
沙美特罗替卡松粉吸入剂联合茶碱缓释片治疗慢性阻塞性肺疾病患者
